November 17, 2014
Predicting adverse drug reactions in patients with Multiple Sclerosis
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
Dr. Haakon Nygaard comes to the Djavad Mowafaghian Centre for Brain Health (DMCBH) from...
For the better part of a century, the neurotransmitter dopamine has been understood as...
Dr. Dan Marigold is currently trying to determine how the brain adapts to altered...
Molecular geneticist Dr. Carles Vilarino-Guell has played an important role in the identification of...
Pictured:The dendrites of one neuron (red), and microglial cells (green). Researchers in Dr. Brian...
Led by Dr. Raymond Lam, researchers at the Mood Disorders Centre at UBC Hospital...
Amyotophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating and...
Young researchers from the National Core for Neuroethics at the Djavad Mowafaghian Centre for...
Although most people take for granted their brain’s ability to be learning almost constantly,...
University of British Columbia researchers have discovered that so-called “sticky synapses” in the brain...
The human brain appears to be no different than rest of the body when...